| Market Cap | ₹8.76Cr |
| ROE | -6.62% |
| P/E Ratio(TTM) | -27.38 |
| EPS(TTM) | -0.08 |
| P/B Ratio | 1.90 |
| Dividend Yield | 0.00% |
| Industry P/E | 32.93 |
| Book Value | 1.15 |
| Debt to Equity | 2.20 |
| Face Value | 1 |
| Parent Organisation | Vivanza Biosciences Limited |
| Managing Director | Mr. Jayendra Mehta |
| BSE Symbol | 530057 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.18 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.75 | ||
| Wockhardt | NA (0.00%) | -421.02 | ||
| Cohance Lifesciences | NA (0.00%) | 65.35 |